Does Wegovy Prevent Pregnancy — What the Evidence Actually Says

What the regulatory guidance says about Wegovy and pregnancy

The UK's medicines regulator has been clear. Semaglutide (the active ingredient in Wegovy) is not recommended in pregnancy. This is reflected in the medicine's Summary of Product Characteristics, in NHS guidance for weight management injections, and in the advice published by NHS England for clinicians and patients using these medicines. The official position is unambiguous: if you are pregnant, planning to become pregnant, or breastfeeding, Wegovy is not suitable.

The reason is partly precautionary. Human safety data in pregnancy is very limited. Animal studies have shown adverse effects on foetal development at exposures used in research, and those findings are enough to make caution the only responsible position. No trial has tested semaglutide in pregnant women, and given what the animal data showed, none is expected to. The science around semaglutide and pregnancy is still developing, and that uncertainty itself is the clinical message: this is not a medicine to remain on if you are pregnant or trying to conceive.

The NHS England guidance on weight management injections advises that women should use effective contraception while on these medicines and for a period afterwards. The MHRA also advises a wash-out period before attempting conception, and if you want to understand whether and how semaglutide affects pregnancy, your prescriber can advise on how long that should be for you personally, because it depends on the medicine and your individual circumstances.

Does Wegovy affect how well the contraceptive pill works?

This is a question our prescribers hear regularly, and it is worth addressing carefully. Wegovy slows gastric emptying, food and other substances move through the stomach more slowly. In theory, that could affect how oral medicines are absorbed, including combined oral contraceptive pills.

For Wegovy specifically, NHS guidance notes there is no strong clinical evidence that it meaningfully reduces oral contraceptive effectiveness in the same way that has been observed with tirzepatide (Mounjaro). The NHS Inform Scotland guidance on weight-loss medicines and contraception reflects this distinction. That said, if you are starting Wegovy or moving up to a higher dose, it is sensible to add a barrier method (condoms, for instance) until you are stable on a dose and have discussed the matter with your GP or prescriber. Erring on the side of caution costs very little.

Non-oral forms of contraception (patches, implants, intrauterine devices, injections) are not affected by gastric emptying at all, making them a straightforward option to discuss with your GP. If the interaction between Wegovy and pregnancy risk is something you are actively thinking about, a conversation with a clinician before or shortly after starting treatment is the right move.

What to do if you become pregnant while taking Wegovy

Stop the medicine. Contact your GP or prescriber the same day. Do not wait for your next scheduled appointment or consultation.

This is not a situation that calls for anxiety, many women have discovered pregnancies while on GLP-1 medicines, because the medicines are taken by a large number of people in their reproductive years. The available data, while limited, does not currently suggest a clear pattern of harm in very early unintentional exposure. But the data is limited, and that is precisely why the medicine should not continue.

Your GP can refer you to appropriate obstetric care and advise on monitoring. The question of resuming Wegovy after a pregnancy (whether after delivery or after deciding not to continue) is one for a prescriber to answer in light of your full medical picture. You can read more about returning to treatment after pregnancy separately. The broader question of how semaglutide may affect a pregnancy is covered in more detail on a dedicated page.

If you have concerns, you can also contact our team via our support page; for clinical questions specific to your treatment, reaching out to a prescriber is always the right first step.

Planning ahead: weight management and conception

If you are thinking about starting a family in the near future, the timing of weight management treatment is worth discussing with a clinician before you begin. Weight loss itself (independent of the medicine) can improve fertility, regulate menstrual cycles, and reduce the risks associated with pregnancy in women living with obesity. That makes the underlying goal of treatment genuinely relevant to reproductive health, even though the medicine itself must be paused before conception.

Many women use a period of treatment to reach a healthier weight, stop the medicine at the recommended point, and then attempt conception. Wegovy's licensed uses and how it works are covered in full on the main treatment page. For those considering treatment more broadly, starting a free consultation is the first step: a GPhC-registered prescriber reviews every application personally, which means your specific circumstances (including any plans around pregnancy) form part of that clinical conversation from the outset. Weight management options across the medicines we support are also outlined on our treatment overview page.

Honest planning now saves complications later. If in doubt, speak to a clinician before starting.